SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Santhera Pharmaceuticals AG's MICONOS Trial with Catena/Sovrima in Friedreich's Ataxia Misses Phase 3 Primary Endpoint